Performance and Trajectory slide image

Performance and Trajectory

Baxter Profile Market-leading positions Broad reach and channel strength Baxter 33% away ww RENAL CARE Chichea clearers Content des cybe www. S wird. OLIMEL 8% storimay tales en kcal Calories non protéiques env. 1260 kcal 13,5 q Azote Ratio calories non protéiques/aaple fusion Glucose Lipides Ratio calories glucidiques/ MOR : 93 kcal/g 165,0 g 60 g Revenue by Business¹ CLINICAL NUTRITION 281322 HOC 03-01 DA 0.9% Sodium Chloride Injection USP 26%* ETERNITY Dr H SEAS OF CLEAR H QUESARAY TO USE VIAFLE BANT JANT fo MEDICATION DELIVERY F Homostati ADVANCED SURGERY 18% 50 mL Iso-osmotic 68 dmt contains: Oxactlin Sodium equivalent Dextrose hydrous, USP added to adjus are Hydrous USP added as a bulter, pl have been adjusted with sodium b aucht so.dis USE PHARMACEUTICALS 4% ACUTE THERAPIES ¹Sales and related figures represent FY 2017; Other sales represent ~4%. | 5
View entire presentation